Signaling by CD40 and its mimics in B cell activation

Immunologic Research

Volumn 24, Issue 2, 2001, Pages 97-109

  Bishop, Gail A ^a   Hostager, Bruce S ^b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

B lymphocyte; CD40; Latent membrane protein 1; Signal transduction; TNF receptor family

Indexed keywords

ANTIGEN; BIOLOGICAL RESPONSE MODIFIER; CD40 ANTIGEN; CD40 LIGAND; IMMUNOGLOBULIN CLASS; LATENT MEMBRANE PROTEIN 1; OLIGONUCLEOTIDE; ONCOPROTEIN; PHOSPHOTRANSFERASE; PROTEIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE ACTIVATION; ENZYME ACTIVATION; EPSTEIN BARR VIRUS; GENE EXPRESSION REGULATION; GERMINAL CENTER; HUMAN; HUMORAL IMMUNITY; IMMUNOGLOBULIN PRODUCTION; MOLECULAR MIMICRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

AMINO ACID SEQUENCE; ANTIGENS, CD40; B-LYMPHOCYTES; CELL TRANSFORMATION, NEOPLASTIC; LYMPHOCYTE ACTIVATION; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; RECEPTORS, CELL SURFACE; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION;

EID: 0034823202     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/IR:24:2:097     Document Type: Article

References (96)

1. + B cells by clonal T cells and antigen
2. The synergistic effects of anti-IgM and monoclonal anti-Ia antibodies in induction of murine B lymphocyte activation
3. Ia-mediated signal transduction leads to proliferation of primed B lymphocytes
4. Requirements of class II-mediated B cell differentiation for class II crosslinking and cAMP
5. Antigen presentation abrogated in cells expressing truncated Ia molecules
6. Characterization of the signaling function of MHC class II molecules during antigen presentation by B cells
7. Signaling through MHC class II molecules blocks CD95-induced apoptosis
8. Separation of events mediating B cell proliferation and Ig production by using T cell membranes and lymphokines
9. B lymphocyte activation by contact-mediated interactions with T lymphocytes
10. A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas
11. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells
12. Defective expression of the CD40 ligand in X chromosome-linked Ig deficiency with normal or elevated IgM
13. CD40 ligand and its role in X-linked hyper-IgM syndrome
14. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM
15. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM
16. Mice deficient for the CD40 ligand
17. The immune responses in CD40-deficient mice: Impaired Ig class switching and germinal center formation
18. CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation
19. The CD40 antigen and its ligand
20. Functions of CD40 and its ligand, gp39
21. Rescue from anti-IgM-induced programmed cell death by the B cell surface proteins CD20 and CD40
22. Opposing roles of CD95 (Fas/APO-1) and CD40 in the death and rescue of human low density tonsillar B cells
23. CD40 ligation induces Fas expression on human B lymphocytes and facilitates apoptosis through the Fas pathway
24. Different CD40-mediated signaling events require distinct CD40 structural features
25. Engagement of CD40 lowers the threshold for activation of resting B cells via antigen receptor
26. Signaling via MHC class II molecules and antigen receptors enhances the B cell response to gp39/CD40 ligand
27. CD54/ICAM-1 and MHC class II signaling induces B cells to express IL-2 receptors and complements help provided through CD40 ligation
28. CD40 and IgE: Synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells
29. Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines
30. CD134L engagement enhances human B cell Ig production: CD154/CD40, CD70/CD27, and CD134/CD134L interactions coordinately regulate T cell-dependent B cell responses
31. Identification of the intracytoplasmic region essential for signal transduction through a B cell activation molecule, CD40
32. CD40 mediated activation of Ig-CγI and Ig-Ce germline promoters involves multiple TRAF family proteins
33. Characterization of CD40 signaling determinants regulating NF-κB activation in lymphocytes
34. Involvement of a common 10-amino acid segment in the cytoplasmic region of CD40 but different MAP kinases in different CD40-mediated responses
35. Identification of distinct domains in CD40 involved in B7-1 induction or growth inhibition
36. TRAFs - A family of adapter proteins that regulates life and death
37. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor
38. A novel RING finger protein interacts with the cytoplasmic domain of CD40
39. TRAF2-mediated activation of NF-kB by TNF receptor 2 and CD40
40. Identification of TRAF6, a novel TRAF protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region
41. Anatomy of TRAF2. Distinct domains for NF-kB activation and association with TNF signaling proteins
42. Involvement of CRAF1, a relative of TRAF, in CD40 signaling
43. TRAF5, an activator of NF-κB and putative signal transducer for the LT-β receptor
44. TRAF5, a novel TNF-R-associated factor family protein, mediates CD40 signaling
45. Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain
46. Ubiquitination: RING for destruction?
47. Recruitment of CD40, TRAF2 and TRAF3 to membrane microdomains during CD40 signaling
48. Engagement of T cell receptor triggers its recruitment to low-density detergent-insoluble membrane domains
49. Membrane compartmentation is required for efficient T cell activation
50. A role for lipid rafts in B cell antigen receptor signaling and antigen targeting
51. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SPAK/JNK and p38 signaling pathways
52. Signaling by proinflammatory cytokines: Oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain
53. TNF signaling to SAPK/JNK and p38. Germinal center kinase couples TRAF2 to MAPK/ERK kinase kinase 1 and SAPK while RIP associates with a MAPKKK upstream of MKK6 and p38
54. TNF-mediated activation of the SAPK pathway: TRAF2 recruits and activates germinal center kinase related
55. Cutting Edge: Contrasting roles of TRAF2 and TRAF3 in CD40-mediated B lymphocyte activation
56. TRAF2 is essential for JNK but not NF-κB activation and regulates lymphocyte proliferation and survival
57. Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice
58. TRAF2 deficiency results in hyperactivity of certain TNFR1 signals and impairment of CD40-mediated responses
59. Characterization of the roles of TRAF6 in CD40-mediated B lymphocyte effector functions
60. TRAF6 deficiency results in osteopetrosis and defective IL-1, CD40, and LPS signaling
61. Membrane-bound CD154, but not anti-CD40 mAbs, induces NF-kB independent B cell IL-6 production
62. Signal transduction via CD40 involves activation of lyn kinase and phosphatidylinositol-3-kinase, and phosphorylation of phospholipase Cγ2
63. Jak3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells
64. Induction of STAT protein signaling through the CD40 receptor in B lymphocytes
65. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB
66. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family
67. Mice deficient in NF-κB/p52 present with defects in humoral responses, GC reactions, and splenic microarchitecture
68. B cells from p50/NF-κB knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching
69. B cells genetically deficient in the c-Rel transactivation domain have selective defects in germline CH transcription and Ig class switching
70. Molecular mechanisms of B lymphocyte activation by the immune response modifier R-848
71. Requirement for NF-κB activation by a distinct subset of CD40-mediated effector functions in B lymphocytes
72. The B cell-specific transcription factor BSAP regulates B cell proliferation
73. STAT6 is required for IL-4-induced germline Ig gene transcription and switch recombination
74. The transcription factor BSAP enhances both IL-4 and CD40-mediated activation of the human e germline promoter
75. Interaction of Stat6 and NF-κB: Direct association and synergistic activation of IL-4-induced transcription
76. Induction of the transcription factors NF-κB, AP-1 and NF-AT during B cell stimulation through the CD40 receptor
77. Modulation of E2F activity in primary mouse B cells following stimulation via surface IgM and CD40 receptors
78. Evidence for a CD40 response element, distinct from the IL-4 response element, in the germline ε promoter
79. Analysis of the promoter elements necessary for IL-4 and anti-CD40 antibody induction of murine CD23. Comparison with the germline ε promoter
80. The roles of human viruses in the pathogenesis of lymphoma
81. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells
82. EBV LMP1 is essential for B-lymphocyte growth transformation: EBV strategy in normal and neoplastic B cells
83. The EBV transforming protein, LMP1, mimics and cooperates with CD40 signaling in B lymphocytes
84. Differential signaling and TRAF regulation by CD40 and the EBV oncoprotein LMP1
85. Immune activation by bacterial DNA: A new genetic code
86. CpG motifs in bacterial DNA trigger direct B cell activation
87. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete IL-6, IL-12, and IFNγ
88. CpG DNA rescue of murine B lymphoma cells from anti-IgM-induced growth arrest and programmed cell death is associated with increased expression of c-myc and bcl-xL
89. The immune response modifier, Resiquimod, mimics CD40-induced B cell activation
90. CpG DNA rescue from anti-IgM-induced WEHI-231 B lymphoma apoptosis via modulation of IκBα and IκBβ and sustained activation of NF-κB
91. How do you see CG?
92. Immune cell activation by bacterial CpG-DNA through MyD88 and TRAF6
93. Inhibition of murine tumor growth by an interferon inducing imidazoquinoline
94. Adjuvant effects of imiquimod on a HSV-2 glycoprotein vaccine in guinea pigs
95. Imiquimod, a patient-applied immune resonse modifier for treatment of external genital warts
96. The immune response modifiers imiquimod and R-848 are potent activators of B lymphocytes